M3554, a novel anti-GD2 antibody drug conjugate.
For research use only. We do not sell to patients.
Name | M3554 |
---|---|
Iupac Chemical Name | (2S,3S,4S,5R,6S)-6-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)acetamido)-4-(((((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamoyl)oxy)methyl)phenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid |
Synonyms | M3554 ; M-3554 ; M 3554 |
Molecular Formula | C47H45FN6O17 |
Molecular Weight | 984.90 |
Smile | CC[C@]1(C(OCC2=C1C=C3N(C2=O)CC4=C5[C@@H](NC(OCC6=CC(NC(CNC(CCN7C(C=CC7=O)=O)=O)=O)=C(C=C6)O[C@@H]8O[C@H](C(O)=O)[C@H]([C@@H]([C@H]8O)O)O)=O) CCC9=C5C(N=C34)=CC(F)=C9C)=O)O |
InChiKey | UNHOOUVLRYPIIK-VBWIOPQNSA-N |
InChi | InChI=1S/C47H45FN6O17/c1-3-47(67)24-13-29-37-22(16-54(29)42(62)23(24)18-68-45(47)65)36-26(6-5-21-19(2)25(48)14-28(51-37)35(21)36)52-46(66)69-17-20-4-7-30(70-44-40(61)38(59)39(60)41(71-44)43(63)64)27(12-20)50-32(56)15-49-31(55)10-11-53-33(57)8-9-34(53)58/h4,7-9,12-14,26,38-41,44,59-61,67H,3,5-6,10-11,15-18H2,1-2H3,(H,49,55)(H,50,56) (H,52,66)(H,63,64)/t26-,38-,39-,40+,41-,44+,47-/m0/s1 |
CAS Number | 2763252-25-9 |
Related CAS | 2763252-25-9 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Yellow solid |
---|---|
Purity | ≧95.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |